Today we are pleased to announce a partnership with the Queen’s University of Belfast (QUB), securing rights to a preclinical stage first-in-class FLIP...
Feb 22 - 24, 2022
On November 23, during the 10th edition of the National Industry Week in France, the Servier Group invited institutions and media to a visit of the...
Grifols, one of the world’s leading producers of plasma-derived medicines with a more than 110-year track record of contributing to the health and well-being...
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that...
ONO Receives Approval of Opdivo for Expanded Use for Two Indications in Japan
Pivotal Phase 3 Trial for Pediatric Praziquantel Completes with Positive Results
Trodelvy Granted EC Marketing Authorization for Treatment of Metastatic TNBC
Takedas LIVTENCITY Approved by US FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant CMV
Bristol Myers Squibb Receives EC Approval of Zeposia
FDA Approves Mercks KEYTRUDA as Adjuvant Therapy or Certain Patients With RCC
Follow-Up Data from Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine
Fresenius Helios Acquires Oncological Center and Ophthalmic Clinic
Merck Completes Acquisition of Acceleron Pharma Inc.
TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan Initiated in Patients
No more news headlines available